ES2172481A1 - Composicion farmaceutica que contiene citalopram. - Google Patents

Composicion farmaceutica que contiene citalopram.

Info

Publication number
ES2172481A1
ES2172481A1 ES200101877A ES200101877A ES2172481A1 ES 2172481 A1 ES2172481 A1 ES 2172481A1 ES 200101877 A ES200101877 A ES 200101877A ES 200101877 A ES200101877 A ES 200101877A ES 2172481 A1 ES2172481 A1 ES 2172481A1
Authority
ES
Spain
Prior art keywords
citalopram
pharmaceutical composition
composition containing
containing citalopram
mixture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES200101877A
Other languages
English (en)
Other versions
ES2172481B2 (es
Inventor
Ken Liljegren
Per Holm
Ole Nielsen
Swen Wagner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
H Lundbeck AS
Original Assignee
H Lundbeck AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26068858&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2172481(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by H Lundbeck AS filed Critical H Lundbeck AS
Publication of ES2172481A1 publication Critical patent/ES2172481A1/es
Application granted granted Critical
Publication of ES2172481B2 publication Critical patent/ES2172481B2/es
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Composición farmacéutica que comprende citalopram, que se prepara por compresión directa de una mezcla de citalopram base, o una de sus sales farmacéuticamente aceptables, y excipientes farmacéuticamente aceptables, o rellenando dicha mezcla en una cápsula de gelatina dura. Cristales grandes de una sal farmacéuticamente aceptable de citalopram y método para la fabricación de dichos cristales grandes.
ES200101877A 2000-08-10 2001-08-09 Composicion farmaceutica que contiene citalopram. Expired - Fee Related ES2172481B2 (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DKPA200001202 2000-08-10
DKPA200001202 2000-08-10
DKPA200001614 2000-10-27
DKPA200001614 2000-10-27

Publications (2)

Publication Number Publication Date
ES2172481A1 true ES2172481A1 (es) 2002-09-16
ES2172481B2 ES2172481B2 (es) 2004-08-01

Family

ID=26068858

Family Applications (1)

Application Number Title Priority Date Filing Date
ES200101877A Expired - Fee Related ES2172481B2 (es) 2000-08-10 2001-08-09 Composicion farmaceutica que contiene citalopram.

Country Status (34)

Country Link
EP (1) EP1318805A2 (es)
JP (1) JP2003531153A (es)
KR (1) KR20030024833A (es)
CN (1) CN1446089A (es)
AR (1) AR030095A1 (es)
AT (1) AT5744U1 (es)
AU (2) AU2001100198B4 (es)
BE (1) BE1013559A6 (es)
BG (1) BG107578A (es)
BR (1) BR0113250A (es)
CA (1) CA2353693C (es)
CH (2) CH694242A5 (es)
CZ (1) CZ2003397A3 (es)
DE (2) DE20113195U1 (es)
EA (1) EA200300247A1 (es)
ES (1) ES2172481B2 (es)
FI (1) FI5176U1 (es)
FR (1) FR2812811B1 (es)
GB (1) GB2368014B (es)
GR (1) GR1004193B (es)
HR (1) HRP20030054A2 (es)
HU (1) HUP0103071A3 (es)
IE (1) IES20010693A2 (es)
IL (1) IL154050A0 (es)
IS (1) IS6021A (es)
IT (1) ITMI20011637A1 (es)
MX (1) MXPA03000837A (es)
NL (1) NL1018741C1 (es)
NO (1) NO20013891L (es)
NZ (1) NZ523785A (es)
PL (1) PL359824A1 (es)
SK (1) SK2842003A3 (es)
WO (1) WO2001080619A2 (es)
YU (1) YU9003A (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2353693C (en) * 2000-08-10 2003-07-22 H. Lundbeck A/S Pharmaceutical composition containing citalopram
AU2001100195B4 (en) * 2001-01-05 2001-12-20 H Lundbeck As Pharmaceutical composition containing citalopram.
GB0206708D0 (en) * 2002-03-21 2002-05-01 Cipla Ltd Pharmaceutical salts
US6812355B2 (en) 2002-10-22 2004-11-02 Sekhsaria Chemicals Limited Process for the manufacture of citalopram hydrobromide from 5-bromophthalide
PL378275A1 (pl) * 2002-12-23 2006-03-20 H. Lundbeck A/S Bromowodorek escitalopramu i sposób jego wytwarzania
WO2004103361A2 (en) * 2003-05-20 2004-12-02 Ranbaxy Laboratories Limited A pharmaceutical dosage form of citalopram
HU227491B1 (en) * 2003-11-25 2011-07-28 Egis Gyogyszergyar Nyilvanosan Muekoedoe Reszvenytarsasag Tablet containing citalopram hydrogen bromide
WO2006038217A1 (en) * 2004-10-05 2006-04-13 Strides Acrolab Limited An improved drug delivery system of citalopram hydrobromide and process for producing the same
US7834201B2 (en) 2005-06-22 2010-11-16 H. Lundbeck A/S Crystalline base of escitalopram and orodispersible tablets comprising escitalopram base
CN100353939C (zh) * 2006-01-05 2007-12-12 昆明积大制药有限公司 含西酞普兰和环糊精的抗抑郁口服药用组合物
GB2480192A (en) * 2007-02-02 2011-11-09 Ubiquisys Ltd Determining the location of a base station
CN106389374A (zh) * 2015-08-03 2017-02-15 深圳信立泰药业股份有限公司 一种含有lcz696的药物组合物及其制备方法
WO2022153262A1 (en) * 2021-01-18 2022-07-21 Anton Frenkel Pharmaceutical dosage form

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1358915A (en) * 1919-04-14 1920-11-16 Amici Domenico Aeroplane
US5296507A (en) * 1990-09-06 1994-03-22 H.Lundbeck A/S Treatment of cerbrovascular disorders
GB2357762A (en) * 2000-03-13 2001-07-04 Lundbeck & Co As H Preparation of Crystalline Base or Salts of Citalopram
EP1152000A1 (en) * 2000-05-02 2001-11-07 SUMIKA FINE CHEMICALS Co., Ltd. Citalopram hydrobromide crystal and method for crystallization thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1358915A (en) * 1971-09-13 1974-07-03 Merck & Co Inc Directly compressed tablet and composition therefor
GB1526331A (en) 1976-01-14 1978-09-27 Kefalas As Phthalanes
GB8419963D0 (en) 1984-08-06 1984-09-12 Lundbeck & Co As H Intermediate compound and method
GB8814057D0 (en) * 1988-06-14 1988-07-20 Lundbeck & Co As H New enantiomers & their isolation
EP0714663A3 (en) * 1994-11-28 1997-01-15 Lilly Co Eli Potentiation of drug responses by serotonin 1A receptor antagonists
GB9714841D0 (en) * 1997-07-14 1997-09-17 Smithkline Beecham Plc Treatment method
CA2353693C (en) * 2000-08-10 2003-07-22 H. Lundbeck A/S Pharmaceutical composition containing citalopram

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1358915A (en) * 1919-04-14 1920-11-16 Amici Domenico Aeroplane
US5296507A (en) * 1990-09-06 1994-03-22 H.Lundbeck A/S Treatment of cerbrovascular disorders
GB2357762A (en) * 2000-03-13 2001-07-04 Lundbeck & Co As H Preparation of Crystalline Base or Salts of Citalopram
EP1152000A1 (en) * 2000-05-02 2001-11-07 SUMIKA FINE CHEMICALS Co., Ltd. Citalopram hydrobromide crystal and method for crystallization thereof

Also Published As

Publication number Publication date
AU2001279591A1 (en) 2001-11-07
GR20010100377A (el) 2002-09-06
BE1013559A6 (fr) 2002-03-05
SK2842003A3 (en) 2003-09-11
ITMI20011637A1 (it) 2003-01-27
PL359824A1 (en) 2004-09-06
CZ2003397A3 (cs) 2003-06-18
IL154050A0 (en) 2003-07-31
EP1318805A2 (en) 2003-06-18
CA2353693C (en) 2003-07-22
AR030095A1 (es) 2003-08-13
DE20113195U1 (de) 2001-11-15
FI5176U1 (fi) 2001-12-27
MXPA03000837A (es) 2003-06-06
HUP0103071A2 (hu) 2002-05-29
CN1446089A (zh) 2003-10-01
NO20013891D0 (no) 2001-08-09
GB2368014A (en) 2002-04-24
FR2812811A1 (fr) 2002-02-15
CH694241A5 (de) 2004-10-15
GR1004193B (el) 2003-03-24
HU0103071D0 (en) 2001-10-28
AT5744U1 (de) 2002-11-25
YU9003A (sh) 2006-05-25
WO2001080619A3 (en) 2002-02-21
NO20013891L (no) 2002-02-11
CA2353693A1 (en) 2002-01-22
GB0118579D0 (en) 2001-09-19
BR0113250A (pt) 2003-06-24
WO2001080619A2 (en) 2001-11-01
NZ523785A (en) 2004-09-24
AU2001100198B4 (en) 2002-06-13
GB2368014B (en) 2004-06-23
AU2001100198A4 (en) 2001-08-16
HRP20030054A2 (en) 2005-02-28
FR2812811B1 (fr) 2006-08-18
BG107578A (bg) 2003-09-30
ES2172481B2 (es) 2004-08-01
NL1018741C1 (nl) 2002-02-12
KR20030024833A (ko) 2003-03-26
HUP0103071A3 (en) 2002-12-28
IS6021A (is) 2001-10-20
ITMI20011637A0 (it) 2001-07-27
IES20010693A2 (en) 2002-07-10
CH694242A5 (de) 2004-10-15
JP2003531153A (ja) 2003-10-21
EA200300247A1 (ru) 2003-06-26
DE10139115A1 (de) 2002-03-28

Similar Documents

Publication Publication Date Title
DE69620606T2 (de) Feste oral anzuwendende arzeneiform
ES2172481A1 (es) Composicion farmaceutica que contiene citalopram.
UA41346C2 (uk) Фармацевтична композиція, яка містить флуоксетин або його сіль, таблетка на її основі, спосіб виробництва таблетки, яка диспергується
RU2003116058A (ru) Композиции гидрокодона с контролируемым высвобождением
DK1117383T3 (da) Doseringsformer omfattende terapeutisk formulering
CA2326517A1 (en) New galenic preparations of meloxicam for oral administration
HUP0301390A2 (hu) Valzartánt tartalmazó orális gyógyászati készítmény
AP2003002763A0 (en) Controlled release formulations for oral administration
RU2003100507A (ru) Фармацевтические композиции
NZ514129A (en) Tolperison-containing, pharmaceutical preparation for oral administration
MXPA03011317A (es) Comprimido masticable que comprende paracetamol.
SE8901003L (sv) Snabbloesliga preparat
HK1079421A1 (en) Oral pharmaceutical composition for soft capsules containing vinorelbine and method of treatment
TNSN06003A1 (en) Saquinavir mesylate oral dosage form
HUP0203148A2 (hu) Mirtazapint tartalmazó orálisan dezintegrálódó készítmény
TW200517127A (en) Novel composition
CA2432177A1 (en) Drug for prevention and/or therapy of endometriosis
YU54503A (sh) Farmaceutski sastav koji sadrži citalopram
GEP20043377B (en) Pharmaceutical Complex
MY131159A (en) New pharmaceutical compositions containing epinastine and pseudoephedrine
RU2002126216A (ru) Фармацевтическая композиция для лечения и профилактики фиброза и цирроза печени
RU96111879A (ru) Способ приготовления гомеопатических мягких лекарственных форм
CA2388431A1 (en) Oral pharmaceutical composition for soft capsules containing vinorelbine and method of treatment
PE20030546A1 (es) Una forma de unidad de dosis farmaceutica del tipo de capsulas rigidas que contiene clonixinato de lisina, un procedimiento para su preparacion y el uso de dicha unidad de dosis como analgesico y/o antiinflamatorio

Legal Events

Date Code Title Description
EC2A Search report published

Date of ref document: 20020916

Kind code of ref document: A1

Effective date: 20020916

FG2A Definitive protection

Ref document number: 2172481B2

Country of ref document: ES

FD1A Patent lapsed

Effective date: 20100412